Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 18 of 18 entries
View as:

Effects of Cyclosporine A on Pancreatic Insulin Secretion

Phase: N/A Priority: Normal
NCT ID: NCT00139035 Org: User:
Start: 04/30/05 End: - Due: -

Association Between Systemic Exposure of Atorvastatin and Metabolites and Atorvastatin-induced Myotoxicity

Phase: N/A Priority: Normal
NCT ID: NCT00120055 Org: User:
Start: 02/28/05 End: 04/30/05 Due: 04/30/06

Metabolic Pattern of Cyclosporine A and Acute Renal Failure

Phase: N/A Priority: Normal
NCT ID: NCT00264355 Org: User:
Start: 12/31/05 End: 06/30/07 Due: 06/30/08

Acetazolamide for Respiratory Failure in Combination With Metabolic Alkalosis

Phase: N/A Priority: Normal
NCT ID: NCT00222534 Org: User:
Start: 01/31/02 End: 12/31/09 Due: 12/31/10

Lowering Total Immunosuppressive Load in Renal Transplant Recipients More Than 12 Months Posttransplant

Phase: N/A Priority: Normal
NCT ID: NCT00148252 Org: User:
Start: 02/28/03 End: 02/28/07 Due: 02/28/08

Investigations on Differences in Atorvastatin Metabolites Ratios as a Diagnostic Tool in Detecting Atorvastatin Induced Myotoxicity

Phase: N/A Priority: Normal
NCT ID: NCT00414531 Org: User:
Start: 05/31/05 End: 06/30/09 Due: 06/30/10

Sitagliptin in Renal Transplant Recipients

Phase: N/A Priority: Normal
NCT ID: NCT00740363 Org: User:
Start: 09/30/08 End: 06/30/12 Due: 06/30/13

Intracellular and Renal/Myocardial Tissue Concentrations of Cyclosporine A (CsA) and Rejection Frequency Following Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT00139009 Org: User:
Start: 06/30/05 End: 09/30/06 Due: 09/30/07

The Rosuvastatin In TrAnsplant Recipients Study

Phase: N/A Priority: Normal
NCT ID: NCT01524601 Org: User:
Start: 02/29/12 End: 10/31/12 Due: 10/31/13

Insulin Secretion and Advagraf

Phase: N/A Priority: Normal
NCT ID: NCT01092806 Org: User:
Start: 10/31/09 End: 05/31/10 Due: 05/31/11

Computer Guided Doing of Tacrolimus in Renal Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT02010320 Org: User:
Start: 01/31/14 End: 07/31/14 Due: 07/31/15

Efficacy and Safety of Nateglinide Treatment in Renal Transplant Recipients

Phase: N/A Priority: Normal
NCT ID: NCT00319189 Org: User:
Start: 11/30/02 End: 11/30/03 Due: 11/30/04

Calcineurin Inhibitor-Free Immunosuppression in Renal Transplant Recipients at Low Immunogenic Risk

Phase: N/A Priority: Normal
NCT ID: NCT00138970 Org: User:
Start: 01/31/02 End: 02/28/05 Due: 02/28/06

Ganciclovir Pharmacokinetics in Patients Undergoing Continuous Renal Replacement Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00264368 Org: User:
Start: 12/31/05 End: 06/30/07 Due: 06/30/08

Prophylactic Effect of Nifedipine on Further Decline in Renal Function in Patients Undergoing Open-Heart Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00244530 Org: User:
Start: 06/30/01 End: 10/31/05 Due: 10/31/06

Investigations on the Influence of Bariatric Surgery on the Metabolism and Absorption of Atorvastatin

Phase: N/A Priority: Normal
NCT ID: NCT00331565 Org: User:
Start: 08/31/06 End: 12/31/10 Due: 12/31/11

Generic Tacrolimus in the Elderly - Prograf® vs Tacni®

Phase: N/A Priority: Normal
NCT ID: NCT01698541 Org: User:
Start: 02/28/13 End: 11/30/13 Due: 11/30/14

Interaction Between Rimonabant and Cyclosporine and Tacrolimus

Phase: N/A Priority: Normal
NCT ID: NCT00525681 Org: User:
Start: 09/30/07 End: 05/31/08 Due: 05/31/09